Medications are a cornerstone of treatment for rheumatoid arthritis (RA). To help doctors and their patients make informed decisions about the many options available, the American College of Rheumatology (ACR) publishes guidelines based on a review of scientific evidence. When writing guidelines, the ACR also invites people with the disease to weigh in on their experiences and preferences. The most recent guideline was published in July 2021.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Arthritis Advisor
Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
